COVIVIO (COV.PA) Stock Fundamental Analysis
Europe - Euronext Paris - EPA:COV - FR0000064578 - REIT
54.5 EUR
+0.1 (+0.18%)
Overall COV gets a fundamental rating of 4 out of 10. We evaluated COV against 42 industry peers in the Diversified REITs industry. While COV is still in line with the averages on profitability rating, there are concerns on its financial health. COV is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
- In the past year COV was profitable.
- In the past year COV had a positive cash flow from operations.
- COV had positive earnings in 4 of the past 5 years.
- COV had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
- The Return On Assets of COV (1.63%) is comparable to the rest of the industry.
- Looking at the Return On Equity, with a value of 5.08%, COV is in line with its industry, outperforming 54.76% of the companies in the same industry.
- COV has a Return On Invested Capital (3.21%) which is comparable to the rest of the industry.
- COV had an Average Return On Invested Capital over the past 3 years of 2.97%. This is in line with the industry average of 3.45%.
- The 3 year average ROIC (2.97%) for COV is below the current ROIC(3.21%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.63% | ||
| ROE | 5.08% | ||
| ROIC | 3.21% |
ROA(3y)-1.05%
ROA(5y)0.29%
ROE(3y)-3.48%
ROE(5y)0.76%
ROIC(3y)2.97%
ROIC(5y)2.68%
1.3 Margins
- COV has a Profit Margin (30.43%) which is in line with its industry peers.
- In the last couple of years the Profit Margin of COV has declined.
- The Operating Margin of COV (57.80%) is worse than 64.29% of its industry peers.
- COV's Operating Margin has been stable in the last couple of years.
- COV's Gross Margin of 74.42% is in line compared to the rest of the industry. COV outperforms 57.14% of its industry peers.
- COV's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 57.8% | ||
| PM (TTM) | 30.43% | ||
| GM | 74.42% |
OM growth 3Y-1.46%
OM growth 5Y-1.11%
PM growth 3Y-61.53%
PM growth 5Y-38.78%
GM growth 3Y-2.18%
GM growth 5Y-0.89%
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), COV is destroying value.
- The number of shares outstanding for COV has been increased compared to 1 year ago.
- The number of shares outstanding for COV has been increased compared to 5 years ago.
- Compared to 1 year ago, COV has an improved debt to assets ratio.
2.2 Solvency
- Based on the Altman-Z score of 0.53, we must say that COV is in the distress zone and has some risk of bankruptcy.
- COV has a worse Altman-Z score (0.53) than 71.43% of its industry peers.
- The Debt to FCF ratio of COV is 28.49, which is on the high side as it means it would take COV, 28.49 years of fcf income to pay off all of its debts.
- COV has a Debt to FCF ratio of 28.49. This is in the lower half of the industry: COV underperforms 71.43% of its industry peers.
- COV has a Debt/Equity ratio of 1.07. This is a high value indicating a heavy dependency on external financing.
- Looking at the Debt to Equity ratio, with a value of 1.07, COV is doing worse than 76.19% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.07 | ||
| Debt/FCF | 28.49 | ||
| Altman-Z | 0.53 |
ROIC/WACC0.56
WACC5.77%
2.3 Liquidity
- A Current Ratio of 0.76 indicates that COV may have some problems paying its short term obligations.
- COV's Current ratio of 0.76 is fine compared to the rest of the industry. COV outperforms 71.43% of its industry peers.
- A Quick Ratio of 0.69 indicates that COV may have some problems paying its short term obligations.
- With a decent Quick ratio value of 0.69, COV is doing good in the industry, outperforming 69.05% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.76 | ||
| Quick Ratio | 0.69 |
3. Growth
3.1 Past
- The Earnings Per Share has been growing slightly by 5.98% over the past year.
- Measured over the past years, COV shows a decrease in Earnings Per Share. The EPS has been decreasing by -3.39% on average per year.
- Looking at the last year, COV shows a very strong growth in Revenue. The Revenue has grown by 27.96%.
- COV shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.17% yearly.
EPS 1Y (TTM)5.98%
EPS 3Y0.91%
EPS 5Y-3.39%
EPS Q2Q%6.25%
Revenue 1Y (TTM)27.96%
Revenue growth 3Y9.01%
Revenue growth 5Y1.17%
Sales Q2Q%-30.61%
3.2 Future
- COV is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 3.57% yearly.
- COV is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.10% yearly.
EPS Next Y5.06%
EPS Next 2Y3.42%
EPS Next 3Y3.57%
EPS Next 5YN/A
Revenue Next Year1.77%
Revenue Next 2Y3.17%
Revenue Next 3Y4.1%
Revenue Next 5YN/A
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 11.82, the valuation of COV can be described as very reasonable.
- Based on the Price/Earnings ratio, COV is valued a bit cheaper than the industry average as 66.67% of the companies are valued more expensively.
- The average S&P500 Price/Earnings ratio is at 27.30. COV is valued rather cheaply when compared to this.
- With a Price/Forward Earnings ratio of 11.40, the valuation of COV can be described as very reasonable.
- COV's Price/Forward Earnings is on the same level as the industry average.
- When comparing the Price/Forward Earnings ratio of COV to the average of the S&P500 Index (24.04), we can say COV is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.82 | ||
| Fwd PE | 11.4 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, COV is valued a bit cheaper than 61.90% of the companies in the same industry.
- The rest of the industry has a similar Price/Free Cash Flow ratio as COV.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 15.49 | ||
| EV/EBITDA | 16.84 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)2.34
PEG (5Y)N/A
EPS Next 2Y3.42%
EPS Next 3Y3.57%
5. Dividend
5.1 Amount
- With a Yearly Dividend Yield of 6.37%, COV is a good candidate for dividend investing.
- COV's Dividend Yield is a higher than the industry average which is at 4.99.
- Compared to an average S&P500 Dividend Yield of 1.92, COV pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 6.37% |
5.2 History
- The dividend of COV decreases each year by -1.54%.
Dividend Growth(5Y)-1.54%
Div Incr Years2
Div Non Decr Years2
5.3 Sustainability
- COV pays out 92.86% of its income as dividend. This is not a sustainable payout ratio.
DP92.86%
EPS Next 2Y3.42%
EPS Next 3Y3.57%
EPA:COV (1/14/2026, 5:36:15 PM)
54.5
+0.1 (+0.18%)
Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)07-21 2025-07-21/bmo
Earnings (Next)02-18 2026-02-18/amc
Inst Owners42.11%
Inst Owner ChangeN/A
Ins Owners0.27%
Ins Owner ChangeN/A
Market Cap6.08B
Revenue(TTM)1.37B
Net Income(TTM)417.40M
Analysts80
Price Target64.71 (18.73%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 6.37% |
Yearly Dividend0.72
Dividend Growth(5Y)-1.54%
DP92.86%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0.72%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.02%
EPS NY rev (3m)-0.02%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)3.02%
Revenue NY rev (3m)-0.05%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.82 | ||
| Fwd PE | 11.4 | ||
| P/S | 4.44 | ||
| P/FCF | 15.49 | ||
| P/OCF | 6.06 | ||
| P/B | 0.74 | ||
| P/tB | 0.77 | ||
| EV/EBITDA | 16.84 |
EPS(TTM)4.61
EY8.46%
EPS(NY)4.78
Fwd EY8.77%
FCF(TTM)3.52
FCFY6.45%
OCF(TTM)8.99
OCFY16.49%
SpS12.29
BVpS73.66
TBVpS70.57
PEG (NY)2.34
PEG (5Y)N/A
Graham Number87.41
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.63% | ||
| ROE | 5.08% | ||
| ROCE | 3.59% | ||
| ROIC | 3.21% | ||
| ROICexc | 3.42% | ||
| ROICexgc | 3.48% | ||
| OM | 57.8% | ||
| PM (TTM) | 30.43% | ||
| GM | 74.42% | ||
| FCFM | 28.62% |
ROA(3y)-1.05%
ROA(5y)0.29%
ROE(3y)-3.48%
ROE(5y)0.76%
ROIC(3y)2.97%
ROIC(5y)2.68%
ROICexc(3y)3.08%
ROICexc(5y)2.79%
ROICexgc(3y)3.11%
ROICexgc(5y)2.81%
ROCE(3y)3.32%
ROCE(5y)3%
ROICexgc growth 3Y12.16%
ROICexgc growth 5Y0.31%
ROICexc growth 3Y11.77%
ROICexc growth 5Y0.14%
OM growth 3Y-1.46%
OM growth 5Y-1.11%
PM growth 3Y-61.53%
PM growth 5Y-38.78%
GM growth 3Y-2.18%
GM growth 5Y-0.89%
F-Score7
Asset Turnover0.05
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.07 | ||
| Debt/FCF | 28.49 | ||
| Debt/EBITDA | 9.39 | ||
| Cap/Depr | 415.79% | ||
| Cap/Sales | 44.53% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 106.78% | ||
| Profit Quality | 94.06% | ||
| Current Ratio | 0.76 | ||
| Quick Ratio | 0.69 | ||
| Altman-Z | 0.53 |
F-Score7
WACC5.77%
ROIC/WACC0.56
Cap/Depr(3y)709.28%
Cap/Depr(5y)708.5%
Cap/Sales(3y)50.08%
Cap/Sales(5y)56.76%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)5.98%
EPS 3Y0.91%
EPS 5Y-3.39%
EPS Q2Q%6.25%
EPS Next Y5.06%
EPS Next 2Y3.42%
EPS Next 3Y3.57%
EPS Next 5YN/A
Revenue 1Y (TTM)27.96%
Revenue growth 3Y9.01%
Revenue growth 5Y1.17%
Sales Q2Q%-30.61%
Revenue Next Year1.77%
Revenue Next 2Y3.17%
Revenue Next 3Y4.1%
Revenue Next 5YN/A
EBIT growth 1Y-0.75%
EBIT growth 3Y7.42%
EBIT growth 5Y0.05%
EBIT Next Year12.83%
EBIT Next 3Y8.07%
EBIT Next 5Y7.52%
FCF growth 1Y41.8%
FCF growth 3YN/A
FCF growth 5Y31.13%
OCF growth 1Y30.51%
OCF growth 3Y12.5%
OCF growth 5Y4.86%
COVIVIO / COV.PA FAQ
Can you provide the ChartMill fundamental rating for COVIVIO?
ChartMill assigns a fundamental rating of 4 / 10 to COV.PA.
What is the valuation status for COV stock?
ChartMill assigns a valuation rating of 5 / 10 to COVIVIO (COV.PA). This can be considered as Fairly Valued.
Can you provide the profitability details for COVIVIO?
COVIVIO (COV.PA) has a profitability rating of 4 / 10.
What is the financial health of COVIVIO (COV.PA) stock?
The financial health rating of COVIVIO (COV.PA) is 1 / 10.
How sustainable is the dividend of COVIVIO (COV.PA) stock?
The dividend rating of COVIVIO (COV.PA) is 4 / 10 and the dividend payout ratio is 92.86%.